BDBM50168588 4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamine::4-(1-ethyl-1H-benzo[d]imidazol-2-yl)-1,2,5-oxadiazol-3-amine::CHEMBL365286

SMILES CCn1c(nc2ccccc12)-c1nonc1N

InChI Key InChIKey=HCRQPXYLXXLKPT-UHFFFAOYSA-N

Data  4 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50168588   

TargetRibosomal protein S6 kinase alpha-5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50168588(4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamin...)
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration exhibited towards MSK-1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase beta-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50168588(4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamin...)
Affinity DataKi:  50nMAssay Description:Inhibition of p70S6K assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/17/2010
Entry Details Article
PubMed
TargetRho-associated protein kinase 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50168588(4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamin...)
Affinity DataKi:  330nMAssay Description:Inhibition of ROCK1 assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/17/2010
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50168588(4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamin...)
Affinity DataKi:  700nMAssay Description:Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/17/2010
Entry Details Article
PubMed
TargetcAMP-dependent protein kinase catalytic subunit alpha(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50168588(4-(1-Ethyl-1H-benzoimidazol-2-yl)-furazan-3-ylamin...)
Affinity DataKi:  960nMAssay Description:Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence ofMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/17/2010
Entry Details Article
PubMed